We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

125 hedge funds and large institutions have $184M invested in Inovio Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

224% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 17

90% more call options, than puts

Call options by funds: $2.27M | Put options by funds: $1.2M

57% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 14

6% more funds holding

Funds holding: 118 → 125 (+7)

5% more capital invested

Capital invested by funds: $176M → $184M (+$8.52M)

0.18% more ownership

Funds ownership: 2.5% → 2.69% (+0.18%)

Holders
125
Holders Change
+7
Holders Change %
+5.93%
% of All Funds
3.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
55
Reduced
17
Closed
14
Calls
$2.27M
Puts
$1.2M
Net Calls
+$1.07M
Net Calls Change
+$30K

Top Buyers

1
State Street
State Street
Massachusetts
+$9.86M
2
BlackRock
BlackRock
New York
+$7.55M
3
Citadel Advisors
Citadel Advisors
Florida
+$3.67M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.43M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.27M

Top Sellers

1
CS
Candriam SCA
Luxembourg
-$744K
2
TCM
Tanaka Capital Management
New York
-$688K
3
ARTA
A.R.T. Advisors
New York
-$618K
4
Goldman Sachs
Goldman Sachs
New York
-$582K
5
PAM
Panagora Asset Management
Massachusetts
-$326K
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$879K +$155K +2,083 +22%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$822K +$64.1K +862 +9%
RTS
28
Round Table Services
New Jersey
$821K – – –
Deutsche Bank
29
Deutsche Bank
Germany
$818K +$300K +4,038 +60%
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$811K +$116K +1,556 +17%
OAM
31
Oxford Asset Management
United Kingdom
$799K +$630K +8,470 +410%
GCP
32
GSA Capital Partners
United Kingdom
$731K -$104K -1,392 -13%
Ohio Public Employees Retirement System (OPERS)
33
Ohio Public Employees Retirement System (OPERS)
Ohio
$674K – – –
Wells Fargo
34
Wells Fargo
California
$657K +$88.9K +1,195 +16%
CS
35
Credit Suisse
Switzerland
$632K +$221K +2,971 +56%
Goldman Sachs
36
Goldman Sachs
New York
$583K -$582K -7,823 -50%
AllianceBernstein
37
AllianceBernstein
Tennessee
$540K -$64.4K -866 -11%
SIP
38
Stoneridge Investment Partners
Pennsylvania
$539K -$91K -1,223 -15%
HighTower Advisors
39
HighTower Advisors
Illinois
$538K +$292K +3,926 +122%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$498K +$8.26K +111 +2%
IG
41
ING Group
Netherlands
$444K +$310K +4,166 +250%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$404K +$56.5K +759 +17%
CS
43
Candriam SCA
Luxembourg
$380K -$744K -10,000 -67%
RE
44
RBC Europe
United Kingdom
$375K +$367K +4,927 New
ProShare Advisors
45
ProShare Advisors
Maryland
$358K +$75.4K +1,013 +27%
AIG
46
American International Group
New York
$342K +$75.5K +1,014 +29%
LCS
47
Levin Capital Strategies
New York
$337K +$184K +2,467 +126%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$333K +$5.95K +80 +2%
LTFS
49
Ladenburg Thalmann Financial Services
Florida
$327K +$11.7K +157 +4%
State of Wisconsin Investment Board
50
State of Wisconsin Investment Board
Wisconsin
$317K – – –
1
2
3 4 5

INO Hedge Fund Activity: Q3 2017 in Review

125 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q3 2017, worth a combined $184M — up 4.8% from $176M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new INO positions and 14 closed out — a net gain of 8 holders — while 55 added to existing stakes and 17 trimmed.

The largest buyer was State Street, adding an estimated $9.86M. The largest seller was Candriam SCA, cutting an estimated $744K.

  • 125 institutional investors held Inovio Pharmaceuticals (INO) as of Q3 2017, up from 118 in Q2 2017.
  • Funds reported $184M of Inovio Pharmaceuticals stock for Q3 2017, up 4.8% quarter-over-quarter.
  • 22 funds opened new Inovio Pharmaceuticals positions in Q3 2017 and 14 closed out, a net change of +8 holders.
  • The largest Inovio Pharmaceuticals buyer in Q3 2017 was State Street, an estimated $9.86M added.
  • The largest Inovio Pharmaceuticals seller in Q3 2017 was Candriam SCA, an estimated $744K sold.

Based on aggregated 13F filings for Q3 2017.